SCHEMBL8355458

SCHEMBL8355458

OCc1cc(C2CC2)nc2ccccc12

nearest known ligand 0.62

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.62
CYP1A2 P05177 1/20 0.47
ALPL P05186 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
PRKAA2 P54646 1/20 0.46
KMT2A Q03164 2/20 0.45
ALDH1A1 P00352 1/20 0.45
HPGD P15428 1/20 0.45
HTT P42858 1/20 0.45
ADAM17 P78536 1/20 0.42
LMNA P02545 1/20 0.42
KDM4E B2RXH2 1/20 0.42
MEN1 O00255 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
TP53 P04637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31732385 1.00 POLB (0.62) POLBCYP1A2ALPLCYP2C9CYP2C19
SCHEMBL28586117 0.92 POLB (0.54) POLBCYP1A2ALPLCYP2C9CYP2C19
SCHEMBL26934006 0.85 POLB (0.56) POLBCYP1A2ALPLCYP2C9CYP2C19
SCHEMBL8355960 0.85 POLB (0.56) POLBCYP1A2ALPLCYP2C9CYP2C19
SCHEMBL29122077 0.83 POLB (0.59) POLBCYP1A2ALPLCYP2C9CYP2C19
SCHEMBL26947842 0.81 POLB (0.52) POLBCYP1A2ALPLCYP2C9CYP2C19
SCHEMBL6479282 0.81 POLB (0.64) POLBCYP1A2ALPLCYP2C9CYP2C19
SCHEMBL28284859 0.79 POLB (0.58) POLBCYP1A2ALPLCYP2C9CYP2C19
SCHEMBL6489161 0.79 POLB (0.61) POLBCYP1A2ALPLCYP2C9CYP2C19
SCHEMBL28581193 0.78 POLB (0.52) POLBCYP1A2ALPLCYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4536667-A1 TRICYCLIC SPIROLACTAM COMPOUNDS WITH ANTIMYCOBACTERIAL ACTIVITY Institut National de la Santé et de la Recherche Médicale (FR) 2025-04-16 EP disclosed
WO-2023237580-A1 TRICYCLIC SPIROLACTAM COMPOUNDS WITH ANTIMYCOBACTERIAL ACTIVITY INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (FR) 2023-12-14 WO disclosed
WO-2023237580-A1 TRICYCLIC SPIROLACTAM COMPOUNDS WITH ANTIMYCOBACTERIAL ACTIVITY INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (FR) 2023-12-14 WO disclosed
US-7598242-B2 Compounds for the treatment of inflammatory disorders SCHERING CORPORATION (US) 2009-10-06 US disclosed
US-7598242-B2 Compounds for the treatment of inflammatory disorders SCHERING CORPORATION (US) 2009-10-06 US disclosed
WO-2003053915-A2 COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS SCHERING CORPORATION (US) 2003-07-03 WO disclosed